Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

The FTC told AstraZeneca that 10 patents related to its Symbicort inhaler, which made $2.54 billion for the company in 2022, may have been improperly or inaccurately listed.